Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study - Summary - MDSpire

Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study

  • By

  • Benita Salomon

  • Padhmanand Sudhakar

  • Daniel Bergemalm

  • Erik Andersson

  • Olle Grännö

  • Marie Carlson

  • Charlotte R H Hedin

  • Johan D Söderholm

  • Lena Öhman

  • the COLLIBRI Consortium the BIO IBD Consortium

  • Ryan C Ungaro

  • Konrad Aden

  • Geert D’Haens

  • Mark S Silverberg

  • Sven Almer

  • Francesca Bresso

  • Adam Carstens

  • Mauro D’Amato

  • Carl Eriksson

  • Henrik Hjortswang

  • Åsa V Keita

  • Maria Ling Lundström

  • Maria K Magnusson

  • Jóhann P Hreinsson

  • Hans Strid

  • Carl Mårten Lindqvist

  • Robert Kruse

  • Dirk Repsilber

  • Bram Verstockt

  • Séverine Vermeire

  • Jonas Halfvarson

  • November 4, 2024

  • 0 min

Share

Objective:

To assess the inflammatory bowel disease (IBD) spectrum based on inflammatory serum proteins and identify discriminative patterns of underlying biological subtypes across multiple European cohorts.

Key Findings:
  • Multiple proteins, including interleukin-17A and matrix metalloproteinase-10, showed significant differences between IBD subtypes, indicating potential biomarkers for differentiation.
  • A protein signature reflecting the IBD spectrum was identified, positioning colonic CD between UC and ileal CD, suggesting a continuum rather than distinct categories.
  • Classification models demonstrated better differentiation between UC and ileal CD than between colonic CD and ileal CD, highlighting the complexity of IBD classification.
Interpretation:

The findings support the existence of a continuous IBD spectrum rather than a strict separation between Crohn's disease and ulcerative colitis. Notably, colonic CD resembles UC more closely than ileal CD, suggesting a need for refined classification.

Limitations:
  • The study relies on pre-existing datasets, which may introduce variability in patient characteristics and data quality.
  • The classification models may not fully capture all aspects of IBD heterogeneity, indicating a need for further refinement.
Conclusion:

The study highlights the need for improved molecular profiling in IBD to better understand its heterogeneity and inform therapeutic strategies, suggesting specific areas for future research.

Original Source(s)

Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study

  • by Benita Salomon, Padhmanand Sudhakar, Daniel Bergemalm, Erik Andersson, Olle Grännö, Marie Carlson, Charlotte R H Hedin, Johan D Söderholm, Lena Öhman, the COLLIBRI Consortium the BIO IBD Consortium, Ryan C Ungaro, Konrad Aden, Geert D’Haens, Mark S Silverberg, Sven Almer, Francesca Bresso, Adam Carstens, Mauro D’Amato, Carl Eriksson, Henrik Hjortswang, Åsa V Keita, Maria Ling Lundström, Maria K Magnusson, Jóhann P Hreinsson, Hans Strid, Carl Mårten Lindqvist, Robert Kruse, Dirk Repsilber, Bram Verstockt, Séverine Vermeire, Jonas Halfvarson

  • November 4, 2024

Related Content

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study